These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29559554)

  • 41. Structural, functional, and behavioral insights of dopamine dysfunction revealed by a deletion in
    Campbell NG; Shekar A; Aguilar JI; Peng D; Navratna V; Yang D; Morley AN; Duran AM; Galli G; O'Grady B; Ramachandran R; Sutcliffe JS; Sitte HH; Erreger K; Meiler J; Stockner T; Bellan LM; Matthies HJG; Gouaux E; Mchaourab HS; Galli A
    Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3853-3862. PubMed ID: 30755521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.
    Mergy MA; Gowrishankar R; Davis GL; Jessen TN; Wright J; Stanwood GD; Hahn MK; Blakely RD
    Neurochem Int; 2014 Jul; 73():56-70. PubMed ID: 24332984
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autism-Associated Variant in the SLC6A3 Gene Alters the Oral Microbiome and Metabolism in a Murine Model.
    DiCarlo GE; Mabry SJ; Cao X; McMillan C; Woynaroski TG; Harrison FE; Reddy IA; Matthies HJG; Flynn CR; Wallace MT; Wu H; Galli A
    Front Psychiatry; 2021; 12():655451. PubMed ID: 33935841
    [No Abstract]   [Full Text] [Related]  

  • 44. Association between the dopamine transporter gene (DAT1) and attention deficit hyperactivity disorder-related traits in healthy adults.
    Jeong SH; Choi KS; Lee KY; Kim EJ; Kim YS; Joo EJ
    Psychiatr Genet; 2015 Jun; 25(3):119-26. PubMed ID: 25915480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter.
    Castelli M; Federici M; Rossi S; De Chiara V; Napolitano F; Studer V; Motta C; Sacchetti L; Romano R; Musella A; Bernardi G; Siracusano A; Gu HH; Mercuri NB; Usiello A; Centonze D
    Eur J Neurosci; 2011 Nov; 34(9):1369-77. PubMed ID: 22034972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Zn(2+) reverses functional deficits in a de novo dopamine transporter variant associated with autism spectrum disorder.
    Hamilton PJ; Shekar A; Belovich AN; Christianson NB; Campbell NG; Sutcliffe JS; Galli A; Matthies HJ; Erreger K
    Mol Autism; 2015; 6():8. PubMed ID: 25741436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1).
    Grünhage F; Schulze TG; Müller DJ; Lanczik M; Franzek E; Albus M; Borrmann-Hassenbach M; Knapp M; Cichon S; Maier W; Rietschel M; Propping P; Nöthen MM
    Mol Psychiatry; 2000 May; 5(3):275-82. PubMed ID: 10889530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A short review on the relation between the dopamine transporter 10/10-repeat allele and ADHD: implications for HIV infection.
    Koutsilieri E; Riederer P; du Plessis S; Scheller C
    Atten Defic Hyperact Disord; 2014 Sep; 6(3):203-9. PubMed ID: 24696011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Good riddance to dopamine: roles for the dopamine transporter in synaptic function and dopamine-associated brain disorders.
    Gowrishankar R; Hahn MK; Blakely RD
    Neurochem Int; 2014 Jul; 73():42-8. PubMed ID: 24231471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Behavioral and pharmacological characteristics of mice lacking the dopamine transporter].
    Biala G
    Postepy Hig Med Dosw (Online); 2004; 58():560-4. PubMed ID: 15765018
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Candidate gene studies of attention-deficit/hyperactivity disorder.
    Faraone SV; Khan SA
    J Clin Psychiatry; 2006; 67 Suppl 8():13-20. PubMed ID: 16961425
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anomalous dopamine release associated with a human dopamine transporter coding variant.
    Mazei-Robison MS; Bowton E; Holy M; Schmudermaier M; Freissmuth M; Sitte HH; Galli A; Blakely RD
    J Neurosci; 2008 Jul; 28(28):7040-6. PubMed ID: 18614672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Dopamine Transporter Recycles via a Retromer-Dependent Postendocytic Mechanism: Tracking Studies Using a Novel Fluorophore-Coupling Approach.
    Wu S; Fagan RR; Uttamapinant C; Lifshitz LM; Fogarty KE; Ting AY; Melikian HE
    J Neurosci; 2017 Sep; 37(39):9438-9452. PubMed ID: 28847807
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic exposure to ethanol of male mice before mating produces attention deficit hyperactivity disorder-like phenotype along with epigenetic dysregulation of dopamine transporter expression in mouse offspring.
    Kim P; Choi CS; Park JH; Joo SH; Kim SY; Ko HM; Kim KC; Jeon SJ; Park SH; Han SH; Ryu JH; Cheong JH; Han JY; Ko KN; Shin CY
    J Neurosci Res; 2014 May; 92(5):658-70. PubMed ID: 24510599
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of intracellular residues in the dopamine transporter critical for regulation of transporter conformation and cocaine binding.
    Loland CJ; Grånäs C; Javitch JA; Gether U
    J Biol Chem; 2004 Jan; 279(5):3228-38. PubMed ID: 14597628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurobehavioral changes arising from early life dopamine signaling perturbations.
    Areal LB; Blakely RD
    Neurochem Int; 2020 Jul; 137():104747. PubMed ID: 32325191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity.
    Miller GM; Yatin SM; De La Garza R; Goulet M; Madras BK
    Brain Res Mol Brain Res; 2001 Feb; 87(1):124-43. PubMed ID: 11223167
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease.
    Herborg F; Jensen KL; Tolstoy S; Arends NV; Posselt LP; Shekar A; Aguilar JI; Lund VK; Erreger K; Rickhag M; Lycas MD; Lonsdale MN; Rahbek-Clemmensen T; Sørensen AT; Newman AH; Løkkegaard A; Kjærulff O; Werge T; ; Møller LB; Matthies HJ; Galli A; Hjermind LE; Gether U
    JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34375312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of rare high-risk copy number variants affecting the dopamine transporter gene in mental disorders.
    Hoeffding LK; Duong LT; Ingason A; Rosengren A; Sorbanski E; Witt SH; Djurovic S; Andreassen OA; Hansen T; Werge T; Rasmussen HB
    Nord J Psychiatry; 2016; 70(4):276-9. PubMed ID: 26559242
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Behaviorally penetrant, anomalous dopamine efflux exposes sex and circuit dependent regulation of dopamine transporters.
    Stewart A; Mayer FP; Gowrishankar R; Davis GL; Areal LB; Gresch PJ; Katamish RM; Peart R; Stilley SE; Spiess K; Rabil MJ; Diljohn FA; Wiggins AE; Vaughan RA; Hahn MK; Blakely RD
    Mol Psychiatry; 2022 Dec; 27(12):4869-4880. PubMed ID: 36117213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.